News
UK pharma major GSK on Friday announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has licensed Blenrep (belantamab mafodotin) in combinations with bortezomib plus ...
2d
Zacks Investment Research on MSNHere's Why GSK (GSK) is a Strong Value StockIt doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
UK-based drug companies AstraZeneca and GSK could be affected by Trump’s next decision, as Karl Matchett reports ...
If the tariff-loving Trump goes ahead with his plans, it will hit AstraZeneca - the most valuable company on the UK stock ...
3d
The National on MSNGSK chief hails Abu Dhabi's 'bold' genome project as health deal is struckAbu Dhabi's agreement with pharmaceutical giant GSK is a “big scientific step forward” in genomic research and medicine, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results